Cellular

Hacking Longevity: Exclusive with Jamie Metzl

Jamie Metzl is a technology and healthcare futurist and geopolitical expert, novelist, entrepreneur, media commentator, and Senior Fellow of the Atlantic Council. In February 2019,...

AgeX & Juvenescence closer to universal allogeneic cells

AgeX and Juvenescence publish progress in development of hypoimmunogenic cells. Longevity focused life sciences companies, AgeX Therapeutics and Juvenescence , today announced the publication...

60 new Biotech and Agetech start-ups to join showcase

Applications open for the Longevity Leaders World Congress start-up showcase. The Longevity sector is in part characterised by the emergence of two exciting classes of...

Researchers pin Longevity hopes on new gene editor

$34M in new Trucode funding could challenge CRISPR domination of genetic engineering market. Have we reached the thin end of the CRISP? For scientists looking...

Latest articles

Small rooms, big opportunities

Thoughts from the floor of the Investing in the Age of Longevity conference. There’s something I love about being in a small conference room discussing...

New xenotransplantation technology raises $100m

eGenesis race to deliver safe xenotransplantation, is this a welcome reset for xeno technology? The transplantation of animal organs to humans is still a relatively...

Gene editing: “fear and excitement in equal measure”

Top lawyer highlights concerns raised by expected growth in gene editing sector. Earlier this year, a major US financial analyst firm identified Longevity as one...

London addresses the 100 year life. Get ready!

Key summit: Increased global Longevity is a “problem of success”. Today, as part of Longevity Week London 2019, we attended the International Longevity Policy and...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.